Administrative Core

行政核心

• 批准号: 10016272
• 负责人: TOM A ELASY
• 金额: $ 12.06万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2022-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10016272
• 关键词: Advisory Committees; Appointment; Area; Attention; Behavior Therapy; Clinic; Collaborations; Communities; Diabetes Mellitus; Doctor of Medicine; Doctor of Philosophy; Effectiveness; Ensure; Faculty; Funding; Goals; Information Technology; Institute of Medicine (U.S.); Internal Medicine; Journals; Leadership; Michigan; North Carolina; Positioning Attribute; Public Health; Research; Research Personnel; Research Training; Resources; Schedule; Schools; Services; Technology; Translational Research; Universities; Update; Visit; Walkers; Work; college; experience; implementation science; medical schools; member; organizational structure; programs; skills; web site

The Vanderbilt CDTR is a distinct organizational, interdisciplinary program involving 38 actively funded faculty distributed among three schools and four colleges of the University. Five additional funded faculty members whose primary appointment is at Meharry Medical School also participate. Under the leadership of Dr. Elasy, the core will be responsible for the allocation and oversight of Center resources and the coordination and integration of the CDTR components and activities. In particular, the administrative core actively coordinates and oversees Pilot and Feasibility activities as well as Enrichment activities. A web site has been created (https://labnodes.vanderbilt.edu/cdtr) and is carefully maintained. There is general continuity in the leadership of the Center with a change in the leadership of a regional core for Behavioral Intervention Technologies and Services (Osborn) and a new leader for the enrichment core (Wilkins). The Vanderbilt CDTR continues under the direction of Tom A. Elasy, M.D., who is PI/Director of the Center. Dr. Elasy is the Ann and Roscoe R. Robinson Chair in the Diabetes Center, Director of the Vanderbilt Division of General Internal Medicine and Public Health, former director of the Vanderbilt Eskind Diabetes Clinic, and has directed the current CDTR for the past 5 years. He is assisted by an Associate Director (Russell Rothman, M.D.) and a Scientific Executive Committee (David Schulndt, Ph.D., Shari Barkin, M.D., Chandra Osborn, Ph.D., Robert Greevey, Ph.D., Consuelo Wilkins, M.D., Margaret Hargraeves, Ph.D.). An internal advisory group consists of Al Powers, M.D. (Director, Vanderbilt Diabetes Research and Training Center), Gordon Bernard, M.D. (Director, Vanderbilt CTSA) and Robert Dittus, M.D., (Director, Vanderbilt Institute for Medicine and Public Health). All three internal advisory members hold senior positions within Vanderbilt enhancing the visibility and effectiveness of the center. This group of investigators brings considerable scientific experience, administrative and managerial skills, and continuity to the Vanderbilt CDTR. An external advisory committee has visited Vanderbilt in conjunction with enrichment activities (Elizabeth Walker, Ph.D. from Einstein, William Herman, M.D. from the University of Michigan, and Thomas Keyserling, M.D. from the University of North Carolina ) and bring national expertise in the areas of disparity research, community engaged research, information technology and implementation science. Dr. Elasy will provide an annual update to the external and internal advisory committee to reflect progress on center goals. The Director, Associate Director and Scientific Executive Committee will meet monthly to review core utilization, discuss enrichment activities, review progress of junior faculty (funded and not yet funded) and consider additional opportunities for collaboration beyond scheduled seminars, journal clubs, and local works-in- progress.

范德比尔特CDTR是一项独特的组织、跨学科的计划，涉及38名积极资助的教师 分布在大学的三所学校和四所学院。新增五名受资助教员 在梅哈里医学院担任主要职务的人也参加了。在埃拉希博士的领导下， 核心将负责中心资源的分配和监督以及协调和 整合CDTR的组成部分和活动。特别是，行政核心积极协调 并监督试点和可行性活动以及浓缩活动。已经创建了一个网站 (https://labnodes.vanderbilt.edu/cdtr))，并仔细维护。 中心的领导总体上是连续的，区域核心的领导发生了变化。 行为干预技术和服务(奥斯本)和浓缩核心的新领导者 (威尔金斯)。范德比尔特CDTR继续在Tom A.Elasy，M.D.的指导下进行，他是 中心。埃拉希博士是糖尿病中心安和罗斯科·R·罗宾逊主席、范德比尔特中心主任 普通内科和公共卫生科，范德比尔特·埃斯金德糖尿病中心前主任 在过去的5年里，他一直在指导目前的CDTR。他由一名副主任协助 (罗素·罗斯曼医学博士)和科学执行委员会(David Schulndt博士、Shari Barkin医学博士、 钱德拉·奥斯本，博士，罗伯特·格里维，博士，康苏埃洛·威尔金斯，医学博士，玛格丽特·哈格拉维斯，博士)。一个 内部咨询小组由Al Power，M.D.(范德比尔特糖尿病研究和培训主任)组成 中心)，Gordon Bernard，M.D.(Vanderbilt CTSA董事)和Robert Dittus，M.D.(Vanderbilt董事 医学和公共卫生研究所)。所有三名内部顾问成员都在 范德比尔特提高了中心的知名度和有效性。这组调查人员带来了 丰富的科学经验、行政和管理技能，以及范德比尔特CDTR的连续性。 一个外部咨询委员会在开展浓缩活动的同时访问了范德比尔特(伊丽莎白 沃克，爱因斯坦的博士，威廉·赫尔曼，密歇根大学的医学博士，托马斯·凯瑟林， 来自北卡罗来纳大学的医学博士)，并带来了差异研究领域的国家专业知识， 社区参与研究、信息技术和实施科学。Elasy博士将提供一个 每年更新外部和内部咨询委员会，以反映中心目标的进展情况。这个 主任、副主任和科学执行委员会将每月开会审查核心利用情况， 讨论充实活动，审查初级教员(已资助和尚未资助)的进度，并考虑 除了预定的研讨会、杂志俱乐部和当地工作外，还有其他合作机会- 进步。